Author

Mykyta V. Kordubailo

Enamine (Ukraine)ORCID 0000-0002-8567-9838Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Microbiology· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Organism:mouse· 1

Frequent Co-Authors

Alpha A. LeeiD· 2 shared Ed GriffeniD· 2 shared A. Pashchenko· 1 shared Andrew Dirksen· 1 shared Annette von DelftiD· 1 shared Anton HlaviniD· 1 shared Anton S. TkachenkoiD· 1 shared Anton Tkachenko· 1 shared

Activity by Year

2025-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersPharmacology & Toxicology

Alpha A. LeeORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Structure-Activity Relationship Studies Towards Analogues of Pleconaril as Novel Enterovirus-D68 Capsid-Targeting Antivirals

David L. Cousins, Ed Griffen, Jessica Stacey, Alpha A. Lee, Yuliia Filimonova, Anton Hlavin, Yuliia Holota, Roman Khmil, Mykyta V. Kordubailo, Oleksii Kostinov, Dmytro S. Lesyk, Ivan G. Logvinenko, Mariia Lototska, Viacheslav Lysenko, A. Pashchenko, , Kris M. White

The paper investigates structure-activity relationships of pleconaril analogues against EV-D68, identifying compounds with antiviral activity and favorable ADME properties.

bioRxiv · Aug 8, 2025 · PreprintPharmacology & Toxicology

Discovery of orally bioavailable Zika virus NS2B-NS3 protease inhibitors with efficacy in a murine infection model

Nathaniel T. Kenton, Haim Michael Barr, Artem Cherepakha, Lotte Coelmont, Caroline Collard, David Cousins, Geraint H. M. Davies, Oleksii Degtyarenko, Andrew Dirksen, Daniel Elbrecht, D. Fearon, James R. Gayvert, Ed Griffen, Dirk Jochmans, Suzanne J. F. Kaptein, , Alpha A. Lee

The paper identifies orally bioavailable inhibitors of the Zika virus NS2B-NS3 protease that show antiviral activity in vitro and reduce viral RNA load in a murine infection model.

bioRxiv · Jun 19, 2025 · PreprintMicrobiology